The Gilson 241 Automated Double Dissolution System (ADDS) was developed with a Major Pharmaceutical company to address the growing need for increased dissolution testing by HPLC. The system controls ...
Over 141,000 bottles of cholesterol medication have been recalled due to “failed dissolution specifications,” suggesting that the drugs did not pass a solubility test, or failed to dissolve at a ...
The British Pharmacopoeia on Monday released its response to its consultation on dissolution testing and announced its plans to update its approach within its product monographs. The British ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results